Contraindicated. Coadministration of doravirine with a robust CYP3A inducer may possibly lower doravirine plasma concentrations and/or effects. Opportunity for loss of virologic reaction and probable resistance to doravirine.Keep track of Carefully (1)pentobarbital will lower the level or influence of tofacitinib by impacting hepatic/intestinal enz